Intramural Funding Opportunities
Extended deadline: January 7
American Cancer Society Individual Research Award
This program is to make seed funding available to encourage junior investigators to initiate promising new projects in cancer-related research that may enable them to compete successfully for national research grants. Funding for this program is supported by a grant from the American Cancer Society.
Deadline: January 14
Oral, Head and Neck Cancer Research Team Awards [Application]
This program will provide funding for up to 3 “Team Science” pilot grants, depending on number and quality of proposals. The goal of these awards is to stimulate collaborations of UCSF scientists from diverse fields, anchored around clinical and translational research questions to address mechanisms of tumorigenesis or metastasis, identify novel therapeutic targets, etc relevant to oral, head and neck cancers. These pilot team awards require innovative and multidisciplinary approaches. Awards will provide pilot funding to develop complex cross-disciplinary research projects, with translational aims in mind. Our hope is to catalyze these partnerships and ultimately apply for an NIH program project and/ or SPORE type of multi-PI award.
Deadline: December 13
Mount Zion Campus-based Awards FY18-19 Cycle
Mount Zion Campus-based Awards are allocated from funds restricted to patient care and education uses at UCSF Mount Zion (research and educational travel funds are allocated through separate processes). MZHF’s goal for utilizing these funds is to encourage UCSF Mount Zion Campus programs to identify and address unmet needs and achieve local and national excellence. Please note that the majority of funding for this grant category is restricted for indigent patient care, pediatric care, cancer care, cardiac care, and medical education. Funds allocated through this award cycle are for core support or start-up, and requests must describe the program or activity’s value to the UCSF Mount Zion Campus.
Deadline: December 17
Rita Allen Foundation & American Pain Society - Award in Pain
Proposed research projects should be directed toward the molecular biology of pain and/or basic science topics related to the development of new analgesics for the management of pain due to terminal illness.
- Please email email@example.com at UCSF to announce your intention to apply.
Deadline: January 7
Global Challenge to Prevent Breast Cancer
The Global Challenge to Prevent Breast Cancer is a competition designed to surface game-changing breast cancer prevention research ideas. This challenge, sponsored by the California Breast Cancer Research Program (CBCRP), aims to advance breast cancer primary prevention by surfacing innovative breast cancer prevention research ideas from researchers and others interested in breast cancer prevention. By providing cash prizes, feedback from respected researchers, and the opportunity to present ideas to prominent leaders in the field, the challenge aims to surface breakthrough ideas that will help catalyze the field of breast cancer primary prevention research. The most promising ideas will frame CBCRP's future funding strategy and will be further developed in California with $15 million in grant funding from the program.
Deadline: January 7
NCCN RFP: Phase I/II Clinical Trials and Correlative Trials of trifluridine/tipiracil for Gastrointestinal and other Solid Tumors
The National Comprehensive Cancer Network (NCCN) has received a Two Million Dollar research grant from Taiho Oncology, Inc. (hereafter, “Grantor”) to support the performance of clinical and correlative studies of trifluridine/tipiracil (FTD/TPI), in the treatment of gastrointestinal (GI) malignancies and other solid tumors. NCCN will serve as the funding organization. Grants are available only to investigators from NCCN Member Institutions.
Deadline: January 23
QuickStart Training Program
The Tobacco-Related Disease Research Program (TRDRP), California Breast Cancer Research Program (CBCRP) and the Orange County Asian and Pacific Islander Community Alliance (OCAPICA) invite you to apply to QuickStart, an innovative three-month program that supports community-academic teams in conducting community-partnered participatory research related to breast cancer or tobacco-related disease. This is a rare opportunity to get technical assistance directly from funders on a research proposal that you develop over the course of the program. QuickStart program gives Fellows a competitive edge when submitting research proposals to any funding agency.
Deadline: February 1
PhRMA Foundation: Health Outcomes Research Starter Grants
Please email Melanie.firstname.lastname@example.org to announce your intention to apply, then follow application instructions in RFP.
LOI Deadline: December 11
NCI Research Specialist Award (R50)
The NCI Research Specialist Award encourages the development of stable research career opportunities for exceptional scientists who want to pursue research within the context of an existing cancer research program, but not serve as independent investigators. These scientists, including researchers within a research program, core facility managers, and data scientists, are vital to sustaining the biomedical research enterprise. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others for career continuity.
Deadline: December 17
Pediatric Immunotherapy-Discovery and Development Network (PI-DDN) (U54)
To view all NCI funding opportunities, search here
To view Cancer Moonshot funding opportunities, search here.